Post-approval oversight ensures long-term product compliance via postmarket surveillance, risk management, pharmacovigilance, change control, and adherence to evolving FDA and Health Canada regulations.
This guide helps determine if your product needs targeted submission support or full regulatory planning for FDA or Health Canada approval, emphasizing strategic compliance and market readiness.
Launching regulated products in the US and Canada requires navigating distinct FDA and Health Canada approvals, bilingual labeling, GMP compliance, accurate classification, importer roles, and ongoing post-market surveillance.
Early regulatory strategy in product development minimizes costly rework, accelerates market entry, and controls costs by aligning FDA/Health Canada requirements, design controls, CMC planning, claims, and clinical strategies from the…
This guide outlines how product classification, intended use, and risk determine FDA and Health Canada regulatory pathways. It emphasizes accurate classification, thorough documentation, pre-submission meetings, and expert consultancy for successful…
Product launches risk delays or rejection by assuming compliance is a last-minute checklist. Avoid this by understanding regulations, planning realistic timelines, conducting gap analyses, and partnering with experts.
Why Your Cosmetic Product Needs an Ingredient Review Before Launch Launching a cosmetic product in today’s regulated market is more than just creating a great formulation. It involves deep regulatory…
Call Now Button